Capmatinib in patients with MET-positive advanced non-small cell lung cancer: analysis of the Russian cohort in the Geometry mono-1 study. Вопр. онкол. [Internet]. 2022 Dec. 27 [cited 2026 Oct. 14];68(6):758-67. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1530